Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTime Finance Regulatory News (TIME)

Share Price Information for Time Finance (TIME)

Share Price is delayed by 15 minutes
Get Live Data
47.00    0.00 (0.00%)
Bid:
46.00
Ask:
48.00
Spread: 2.00 (4.348%)
Market Cap: £43.09m
TIME Live PriceLast checked at - London Stock Exchange

Intraday Time Finance Share Chart

Q3 Trading Update

24 Mar 2026 07:00

RNS Number : 7579X
Time Finance PLC
24 March 2026
 

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

 

24 March 2026

Time Finance plc

(the "Group" or the "Company")

 

Q3 TRADING UPDATE

 

Record Lending Book and Record Nine-Month Revenues and Profits Before Tax

 

Time Finance plc, the AIM listed independent specialist finance provider, is pleased to provide a trading update for the nine-month period ended 28 February 2026 ("9M 2025/26"). The Group's strong performance in the first half of the current financial year has been maintained throughout the third quarter. Continued demand from UK businesses for the Group's multi-product funding offering has driven further growth in the gross lending book which stands at a record high of more than £236m at the end of February 2026. This is the nineteenth consecutive quarter of loan book growth for the Company.

 

Unaudited Nine Month 2025/26 Highlights

· Own-Book lending origination up 27% to £86.5m (9M 2024/25: £69.3m)

· Revenue up 4% to £28.3m (9M 2024/25: £27.3m)

· Profit before Tax up 5% to £6.2m (9M 2024/25: £5.9m)

· PBT margin improved by 100 bps to 22% (9M 2024/25: 21%)

· Net Tangible Assets up 13% to £48.5m at 28 February 2026 (28 February 2025: £43.0m)

· Gross lending-book up 12% to a record £236.4m at 28 February 2026 (28 February 2025: £210.2m)

· Deferred income up 10% to £29.1m at 28 February 2026 (28 February 2025: £26.4m), providing strong visibility of future earnings

· Net Arrears improved to 4.7% of the gross lending book at 28 February 2026 (28 February 2025: 5.3%)

· Net Bad Debt Write-Offs improved to 1.0% of the average lending book at 28 February 2026 (28 February 2025: 1.3%)

 

A key element of the Company's strategy is to focus on more secured lending. This is to be achieved primarily though the provision of Invoice Finance and the 'Hard' element of Asset Finance. These two core areas have accounted for 96% of new lending volume originated in the nine months of trading to 28 February 2026 (9M 2024/25: 91%), and now make up 88% of the total lending book (28 February 2025: 81%).

 

The continued positive trading momentum leads to the expectation that Group financial performance for the full year will be in line with market guidance.

 

Ed Rimmer, Chief Executive Officer commented:

"To be able to report all-time record nine-month Group Revenue and Profit Before Tax in what remain challenging macro-economic conditions is particularly pleasing. To have made these strides forward while maintaining robust credit criteria, as shown by the continued improvement in our arrears and our write-offs, is another key performance indicator that we feel underlines the robust nature of the business.

 

"As a result of all these factors, and as we near the end of the first year of our three-year growth strategy through to May 2028, the Board has confidence that the Group remains well placed to continue building long-term value for all our shareholders."

 

For more information and the chance to have your questions directly answered by the management team, please head to our interactive investor hub via: https://investors.timefinance.com/s/71ba43. Here you will find all company news and additional content to further explain Time Finance's strategy and developments.

 

Ends

 

 

For further information, please contact:

Time Finance plc

01225 474230

Ed Rimmer (CEO) / James Roberts (CFO)

ir@timefinance.com

Cavendish (NOMAD and Broker)

0207 220 0500

Ben Jeynes / Teddy Whiley (Corporate Finance)

Michael Johnson / Matt Lewis (Sales and ECM)

Walbrook PR

0207 933 8780

Nick Rome / Marcus Ulker

Timefinance@walbrookpr.com

 

 

Subscribe to our news alert service: https://investors.timefinance.com/auth/signup

 

About Time Finance:

Time Finance's purpose is to help UK businesses thrive and survive through the provision of flexible funding facilities. It offers a multi-product range for SMEs primarily concentrating on Asset Finance, Invoice Finance and Secured Loans. While focused on being an 'own-book' lender, the Group does retain the ability to broke-on deals where appropriate, enabling it to optimize business levels through market and economic cycles.

 

More information is available on the Company website, www.timefinance.com, and the interactive investor hub, https://investors.timefinance.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSRVFIVFIR
Date   Source Headline
15th Nov 202312:54 pmRNSChange of Nominated Adviser & Corporate Broker
9th Nov 20237:00 amRNSTrading Update
7th Nov 202311:45 amRNSResult of AGM
23rd Oct 20238:30 amRNSDirector Share Purchase
19th Oct 20237:00 amRNSDirector Share Purchase
11th Oct 20237:00 amRNSDirector Share Purchases
3rd Oct 20237:00 amRNSDirector/PDMR Shareholdings: Vesting of Options
27th Sep 20238:30 amRNSNotice of AGM
26th Sep 20237:00 amRNSQ1 Trading Update
26th Sep 20237:00 amRNSFinal Results
19th Sep 20237:00 amRNSAppointment of Independent Non-Executive Directors
12th Sep 20237:00 amRNSOwn-Book Update, Notice of Results, Pres & AGM
11th Jul 20237:00 amRNSDirector Share Purchase
29th Jun 20237:00 amRNSFull Year Trading Update
24th May 20239:04 amRNSDelivery of First Asset-Based Lending Facility
3rd May 20237:00 amRNSTrading Update & Notice of Final Results
8th Mar 20237:00 amRNSQ3 Trading Update: Pre-Tax Profits up 172%
9th Feb 202311:40 amRNSHolding in Company
26th Jan 202311:05 amRNSSecond Price Monitoring Extn
26th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSInterim Results
20th Dec 20221:24 pmRNSExercise of Options & Director/PDMR Shareholding
16th Dec 20227:00 amRNSH1 Trading Update & Notice of Interim Results
14th Nov 20227:00 amRNSDirector Share Purchases
3rd Nov 20227:00 amRNSMelloLondon Investor Conference
31st Oct 20222:00 pmRNSResult of AGM
19th Oct 20227:00 amRNSOwn Book Lending Portfolio reaches record £145m
5th Oct 20227:00 amRNSDirector Share Purchase
4th Oct 202212:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20222:15 pmRNSNotice of AGM
22nd Sep 20227:00 amRNSQ1 Trading Update
22nd Sep 20227:00 amRNSFinal Results for the year ended 31 May 2022
15th Sep 20227:00 amRNSNotice of Results & Q1 Update and Presentation
6th Sep 20227:00 amRNSAppointments Strengthen Asset Finance Division
22nd Jul 20227:00 amRNSNew LTIP & Director/PDMR Shareholding
19th Jul 20227:02 amRNSDirector Share Purchases
18th Jul 20227:00 amRNSDirector Share Purchase
7th Jul 20227:00 amRNSTrading Update & Notice of Final Results
10th Jun 20227:00 amRNSNotice of Trading Update and Investor Presentation
5th May 20229:19 amRNSHolding in Company
27th Apr 20223:28 pmRNSHolding in Company
27th Apr 202212:51 pmRNSHolding in Company
26th Apr 20223:30 pmRNSTR-1 Holding in Company
26th Apr 20229:36 amRNSTR-1 Holding in Company
14th Feb 202210:00 amRNSExercise of Options & Director/PDMR Shareholdings
20th Jan 20227:00 amRNSInterim Results
5th Jan 20227:00 amRNSNotice of Interim Results Investor Presentation
15th Dec 20217:00 amRNSH1 Trading Update & Notice of Interim Results
21st Oct 20213:40 pmRNSResult of AGM & Directorate Change
1st Oct 20217:00 amRNSVesting of Share Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.